Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Impacted Mandibular Third Molar Extraction
NCT07918092Completed
- Sponsor
- Bolu Abant Izzet Baysal University
- Start
- Oct 2023
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Randomised trial of methylprednisolone injection in Impacted Mandibular Third Molar (IM3M) (3 arms), sponsored by Bolu Abant Izzet Baysal University. Primary endpoints: Change in Serum C-Reactive Protein Levels at day 7 and Postoperative Pain Intensity (VAS) at day 7. Started Oct 2023; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
Impacted Mandibular Third Molar (IM3M)
Beyond the preview
Go deeper on NCT07918092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07918092.